Seoulin Bioscience Co.,Ltd. (KOSDAQ: 038070)

Seoulin Bioscience Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8,111	14,602	8,999	14,973	8,498	4,543
Short-Term Investments	16,606	20,722	41,319	40,360	11,362	17,497
Trading Asset Securities	92.41	90.3	4,962	19,999	-	-
Cash & Short-Term Investments	24,810	35,414	55,280	75,332	19,860	22,040
Cash Growth	-56.20%	-35.94%	-26.62%	279.32%	-9.89%	126.50%
Accounts Receivable	6,463	12,986	6,652	10,137	8,840	8,246
Other Receivables	351.97	1,292	630.36	196.33	68.33	132.08
Receivables	6,818	14,294	7,282	10,333	8,908	8,399
Inventory	22,488	21,785	17,307	13,933	11,748	12,030
Prepaid Expenses	67.7	53.74	51.32	32.59	20.85	26.54
Other Current Assets	2,978	1,408	7,366	5,352	924.78	1,307
Total Current Assets	57,162	72,955	87,287	104,983	41,462	43,803
Property, Plant & Equipment	17,182	18,914	16,491	14,937	14,541	25,920
Long-Term Investments	17,563	17,512	25,555	7,515	6,303	6,084
Goodwill	526.49	526.49	526.49	526.49	526.49	526.49
Other Intangible Assets	406.15	425.08	266.64	230.54	319.14	405.58
Long-Term Deferred Tax Assets	2,306	2,259	1,269	2,766	2,655	1,999
Long-Term Deferred Charges	117.36	156.08	210.96	558.01	1,715	1,879
Other Long-Term Assets	2,512	1,335	3,840	5,051	10,725	89.36
Total Assets	97,793	114,100	135,486	136,566	78,247	80,707
Accounts Payable	5,032	11,428	8,603	10,888	6,450	8,335
Accrued Expenses	419.93	387.97	373.05	329.11	278.89	351.73
Short-Term Debt	1,362	6,120	17,469	15,259	142.7	138
Current Portion of Long-Term Debt	-	-	62.5	256.25	229.9	18.75
Current Portion of Leases	204.16	271.44	69.22	34.65	3.07	15.59
Current Income Taxes Payable	443.42	700.11	730.13	4,561	749.54	2,700
Other Current Liabilities	4,022	9,122	19,058	28,112	5,679	4,170
Total Current Liabilities	11,484	28,030	46,365	59,440	13,533	15,729
Long-Term Debt	98.6	98.6	98.47	154.85	368.75	81.25
Long-Term Leases	96.33	224.29	86.11	32.85	9.92	4.42
Other Long-Term Liabilities	462.35	253.48	151.59	150	1,781	1,781
Total Liabilities	12,909	28,861	46,701	60,064	16,864	19,444
Common Stock	4,450	4,350	4,250	4,150	4,000	3,750
Additional Paid-In Capital	18,519	18,519	18,519	18,490	18,490	18,490
Retained Earnings	68,183	67,177	68,475	58,805	44,024	40,280
Treasury Stock	-4,434	-3,404	-3,261	-3,062	-2,981	-2,812
Comprehensive Income & Other	-2,623	-3,581	-3,581	-3,523	-3,613	-
Total Common Equity	84,095	83,063	84,403	74,861	59,920	59,708
Minority Interest	789.35	2,177	4,382	1,642	1,463	1,555
Shareholders' Equity	84,884	85,239	88,785	76,502	61,383	61,263
Total Liabilities & Equity	97,793	114,100	135,486	136,566	78,247	80,707
Total Debt	1,761	6,714	17,785	15,738	754.35	258.01
Net Cash (Debt)	23,049	28,700	37,495	59,594	19,105	21,782
Net Cash Growth	-36.13%	-23.46%	-37.08%	211.92%	-12.29%	171.74%
Net Cash Per Share	2696.37	3352.15	3528.86	6939.33	2223.21	2502.77
Filing Date Shares Outstanding	8.44	8.56	8.37	8.38	8.27	8.06
Total Common Shares Outstanding	8.44	8.56	8.57	8.59	8.59	8.06
Working Capital	45,677	44,924	40,922	45,543	27,928	28,074
Book Value Per Share	9958.87	9701.74	9844.86	8719.17	6973.14	7411.08
Tangible Book Value	83,162	82,111	83,610	74,104	59,074	58,776
Tangible Book Value Per Share	9848.42	9590.60	9752.35	8631.00	6874.73	7295.39
Land	3,967	4,246	3,721	3,185	3,118	6,593
Buildings	11,352	12,539	11,192	10,642	10,563	18,251
Machinery	1,448	1,474	1,193	851.95	631.66	827.41
Construction In Progress	-	-	6	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.